Drug intelligence / Profile preview

isoflupredone

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intramuscular, Intravenous, Topical, Intrasynovial
01

Overview

Isoflupredone is a synthetic corticosteroid used primarily in veterinary medicine for its potent anti-inflammatory and immunosuppressive effects. It acts as an agonist at both glucocorticoid and mineralocorticoid receptors, modulating gene transcription and protein synthesis to reduce inflammation and immune responses. Isoflupredone is commonly administered as the acetate ester (isoflupredone acetate) via injectable or topical formulations, with FDA approval for use in horses, cattle, and pigs. Indications include treatment of musculoskeletal disorders, allergic reactions, recurrent airway obstruction (heaves), ketosis in cattle, shock, hypersensitivity reactions, infections with severe toxicity, and other inflammatory diseases. The drug exhibits both disease-modifying and symptom-modifying effects but requires careful use due to risks such as delayed wound healing or hypokalemia[4][5][7][8].

Brand names
PredefPredef 2XPredef2XPredef-2X
Other names
9-fluoroprednisolonedelta-fluorocortisoneisoflupredonaisoflupredonum
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on isoflupredone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isoflupredone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call